State Street’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,166,002
Closed -$10.6M 4361
2025
Q2
$10.6M Sell
1,166,002
-22,572
-2% -$166K ﹤0.01% 2564
2025
Q1
$9.45M Sell
1,188,574
-84,076
-7% -$616K ﹤0.01% 2559
2024
Q4
$6.91M Sell
1,272,650
-1,653,589
-57% -$10.1M ﹤0.01% 2820
2024
Q3
$21.1M Buy
2,926,239
+451,377
+18% +$4.13M ﹤0.01% 2174
2024
Q2
$26.9M Sell
2,474,862
-2,019,934
-45% -$25.9M ﹤0.01% 2008
2024
Q1
$84.2M Buy
4,494,796
+576,574
+15% +$13.3M ﹤0.01% 1419
2023
Q4
$84.9M Sell
3,918,222
-460,245
-11% -$9.12M ﹤0.01% 1404
2023
Q3
$90.1M Buy
4,378,467
+2,079,327
+90% +$60.1M 0.01% 1248
2023
Q2
$108M Sell
2,299,140
-435,233
-16% -$21.7M 0.01% 1164
2023
Q1
$115M Buy
2,734,373
+7,077
+0.3% +$304K 0.01% 1092
2022
Q4
$104M Sell
2,727,296
-227,387
-8% -$8.68M 0.01% 1138
2022
Q3
$116M Buy
2,954,683
+20,619
+0.7% +$797K 0.01% 1022
2022
Q2
$94.8M Buy
2,934,064
+98,708
+3% +$3.31M 0.01% 1192
2022
Q1
$93.8M Buy
2,835,356
+666,826
+31% +$25.1M ﹤0.01% 1334
2021
Q4
$92.2M Buy
2,168,530
+192,578
+10% +$8.06M ﹤0.01% 1359
2021
Q3
$87.6M Buy
1,975,952
+639,194
+48% +$29.3M ﹤0.01% 1385
2021
Q2
$75.9M Buy
1,336,758
+79,368
+6% +$5.61M ﹤0.01% 1527
2021
Q1
$94.1M Sell
1,257,390
-275,489
-18% -$22.6M 0.01% 1280
2020
Q4
$133M Buy
1,532,879
+44,480
+3% +$3.28M 0.01% 948
2020
Q3
$91M Sell
1,488,399
-628,937
-30% -$31.9M 0.01% 1030
2020
Q2
$88M Buy
2,117,336
+432,202
+26% +$15.7M 0.01% 1051
2020
Q1
$48.4M Buy
1,685,134
+27,262
+2% +$1.58M ﹤0.01% 1267
2019
Q4
$120M Buy
1,657,872
+618,273
+59% +$76.1M 0.01% 934
2019
Q3
$146M Buy
1,039,599
+84,138
+9% +$14.1M 0.01% 802
2019
Q2
$175M Sell
955,461
-90,983
-9% -$15.5M 0.01% 738
2019
Q1
$166M Sell
1,046,444
-14,390
-1% -$2.08M 0.01% 739
2018
Q4
$102M Buy
1,060,834
+55,289
+5% +$6.33M 0.01% 900
2018
Q3
$142M Buy
1,005,545
+8,139
+0.8% +$1.26M 0.01% 860
2018
Q2
$156M Sell
997,406
-235,772
-19% -$37M 0.01% 786
2018
Q1
$199M Buy
1,233,178
+109,506
+10% +$18.6M 0.02% 696
2017
Q4
$185M Sell
1,123,672
-119,093
-10% -$11.5M 0.01% 718
2017
Q3
$77.4M Buy
1,242,765
+30,381
+3% +$2.39M 0.01% 1128
2017
Q2
$96.6M Buy
1,212,384
+87,097
+8% +$6.3M 0.01% 977
2017
Q1
$80M Sell
1,125,287
-32,378
-3% -$1.9M 0.01% 1068
2016
Q4
$59.1M Sell
1,157,665
-12,836
-1% -$605K 0.01% 1176
2016
Q3
$53.9M Buy
1,170,501
+241,028
+26% +$9.81M 0.01% 1187
2016
Q2
$28M Buy
929,473
+204,516
+28% +$6.82M ﹤0.01% 1514
2016
Q1
$23.2M Buy
724,957
+193,022
+36% +$6.79M ﹤0.01% 1624
2015
Q4
$31M Sell
531,935
-92,789
-15% -$4.6M ﹤0.01% 1429
2015
Q3
$26.4M Buy
624,724
+142,909
+30% +$8.81M ﹤0.01% 1563
2015
Q2
$35.2M Buy
481,815
+406,871
+543% +$26.2M ﹤0.01% 1474
2015
Q1
$3.76M Buy
74,944
+2,072
+3% +$89.1K ﹤0.01% 2724
2014
Q4
$2.67M Buy
72,872
+24,772
+52% +$923K ﹤0.01% 2911
2014
Q3
$1.51M Buy
+48,100
New +$1.39M ﹤0.01% 3131

Other funds holding SAGE